BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19555535)

  • 1. Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.
    O'Donnell MR; Padayatchi N; Master I; Osburn G; Horsburgh CR
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):855-61. PubMed ID: 19555535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
    Dheda K; Shean K; Zumla A; Badri M; Streicher EM; Page-Shipp L; Willcox P; John MA; Reubenson G; Govindasamy D; Wong M; Padanilam X; Dziwiecki A; van Helden PD; Siwendu S; Jarand J; Menezes CN; Burns A; Victor T; Warren R; Grobusch MP; van der Walt M; Kvasnovsky C
    Lancet; 2010 May; 375(9728):1798-807. PubMed ID: 20488525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
    Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.
    Yuengling KA; Padayatchi N; Wolf A; Mathema B; Brown T; Horsburgh CR; OʼDonnell MR
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):474-480. PubMed ID: 30212394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.
    Pepper DJ; Rebe K; Morroni C; Wilkinson RJ; Meintjes G
    PLoS One; 2009; 4(2):e4520. PubMed ID: 19229341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.
    Hicks RM; Padayatchi N; Shah NS; Wolf A; Werner L; Sunkari VB; O'Donnell MR
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1074-83. PubMed ID: 25189555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.
    Padayatchi N; Gopal M; Naidoo R; Werner L; Naidoo K; Master I; O'Donnell MR
    J Antimicrob Chemother; 2014 Nov; 69(11):3103-7. PubMed ID: 24986495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
    Nkurunziza J; Karstaedt AS; Louw R; Padanilam X
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1469-1474. PubMed ID: 30606319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
    Gandhi NR; Moll A; Sturm AW; Pawinski R; Govender T; Lalloo U; Zeller K; Andrews J; Friedland G
    Lancet; 2006 Nov; 368(9547):1575-80. PubMed ID: 17084757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.
    Shah NS; Auld SC; Brust JC; Mathema B; Ismail N; Moodley P; Mlisana K; Allana S; Campbell A; Mthiyane T; Morris N; Mpangase P; van der Meulen H; Omar SV; Brown TS; Narechania A; Shaskina E; Kapwata T; Kreiswirth B; Gandhi NR
    N Engl J Med; 2017 Jan; 376(3):243-253. PubMed ID: 28099825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.
    O'Donnell MR; Jarand J; Loveday M; Padayatchi N; Zelnick J; Werner L; Naidoo K; Master I; Osburn G; Kvasnovsky C; Shean K; Pai M; Van der Walt M; Horsburgh CR; Dheda K
    Ann Intern Med; 2010 Oct; 153(8):516-22. PubMed ID: 20956708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    OʼDonnell MR; Pillay M; Pillay M; Werner L; Master I; Wolf A; Mathema B; Coovadia YM; Mlisana K; Horsburgh CR; Padayatchi N
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):536-43. PubMed ID: 25886924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.